Atıf Formatları
Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

K. Altundag Et Al. , "Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain," Onkologie , vol.35, no.5, pp.254-258, 2012

Altundag, K. Et Al. 2012. Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain. Onkologie , vol.35, no.5 , 254-258.

Altundag, K., DİZDAR, Ö., Ozsaran, Z., Ozkok, S., Saip, P., Eralp, Y., ... Komurcu, S.(2012). Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain. Onkologie , vol.35, no.5, 254-258.

Altundag, Kadri Et Al. "Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain," Onkologie , vol.35, no.5, 254-258, 2012

Altundag, Kadri Et Al. "Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain." Onkologie , vol.35, no.5, pp.254-258, 2012

Altundag, K. Et Al. (2012) . "Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain." Onkologie , vol.35, no.5, pp.254-258.

@article{article, author={Kadri Altundag Et Al. }, title={Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain}, journal={Onkologie}, year=2012, pages={254-258} }